Avaí Bio, Inc. AVAI
$0.12
$0.0113.93%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 358.52% | -82.04% | |||
| Depreciation & Amortization | -20.00% | 0.00% | |||
| Other Operating Expenses | -- | -332.50% | |||
| Total Operating Expenses | 3,077.30% | -102.55% | |||
| Operating Income | -3,077.30% | 102.55% | |||
| Income Before Tax | -116.30% | 53.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -116.30% | 53.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -116.30% | 53.91% | |||
| EBIT | -3,077.30% | 102.55% | |||
| EBITDA | -2,102.42% | 103.78% | |||
| EPS Basic | -100.00% | 55.00% | |||
| Normalized Basic EPS | -90.91% | 56.00% | |||
| EPS Diluted | -100.00% | 55.00% | |||
| Normalized Diluted EPS | -90.91% | 56.00% | |||
| Average Basic Shares Outstanding | 10.91% | 0.54% | |||
| Average Diluted Shares Outstanding | 10.91% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||